Foetal hepatorenal toxicity and intrauterine growth retardation in pregnant Wistar rats treated with artemether
Objectives: Foetal hepatorenal toxicity and foetal morphology were evaluated following artemether administration to pregnantWistar albino rats.Methods: Twenty pregnant Wistar rats weighing between 180–200 g were divided into four groups (n=5, each) with Group 1serving as the control. Groups 2, 3 and 4 received 1.1 mg, 2.2 mg and 3.3 mg per kilogram body weight artemether, respectivelyorally, twice daily for three days on day 7, 8 and 9 of pregnancy. The animals were sacrificed on day 20 of pregnancy and foetuseswere harvested and evaluated for morphological changes. Foetal body weight and crown-rump length (CRL) were measured;alpha-fetoprotein (AFP) was assayed using amniotic fluid, and foetal kidney and liver were evaluated histologically for toxicity.Results: There was a significant decrease in body weight, CRL and AFP of the treated groups compared to the control. The foetalliver of the treated groups revealed distorted cytoarchitecture, marked hepatocyte inflammation and hepatic necrosis. The foetalkidney of artemether-treated groups also showed disorganised renal structure, atrophic and degenerated glomeruli with acutetubular necrosis.Conclusion: Artemether administration to pregnant albino rats causes intrauterine growth retardation or stunted growth,as well as foetal hepatorenal toxicity.
___
- 1. World Health Organisation. WHO global malaria programme:
World Malaria Report 2014. Geneva: WHO Press; 2014.
- 2. World Health Organisation. The WHO prequalification project.
The global portfolio of new antimalarial medicines under development.
Clin Pharmacol Ther 2009;85:584–95.
- 3. Burke E, Deasy J. Hasson R, McCormack R, Randhawa V, Walsh P.
Antimalarial drugs from nature. Trinity Student Medical Journal
2003;4:19.
- 4. Mayxay M, Thongpraseuth V, Khanthavong M, Lindegardh N,
Barends M, Keola S, Pongvongsa T, Phompida S, Phetsouvanh R,
Stepniewska K, White NJ, Newton PN. An open, randomised
comparison of artesunate plus mefloquine vs dihydroartemisininpiperaquine
for the treatment of uncomplicated Plasmodium falciparum
malaria in the Lao People’s Democratic Republic (Laos).
Trop Med Int Health 2006;11:1157–65.
- 5. Faye B, Ndiaye JL, Tine R, Sylla K, Gueye AH, Colle LA, Gaye OA.
Randomised trial of artesunate/mefloquine vs artemether/lumefantrine
for the treatment of uncomplicated Plasmodium falciparum
malaria in Senegalese children. Am J Trop Med Hyg 2010;82:140–4.
- 6. Frey SG, Chelo D, Kinkela MN, Djouknone F, Tietche F, Hatz C,
Weber P. Artesunate-mefloquine combination therapy in acute
Plasmodium falciparum malaria in young children: a field study
regarding neurological and neuropsychiatric safety. Malar J 2010;9:
291–9.
- 7. Akpanyung EO, Bassey UE, Usoh I, Iba IU. Effect of combined
administration of artequin and pefloxacin on some indices of liver and
renal functions of male Wistar albino rats. PharmacologyOnLine
2015;3:84–90.
- 8. Etim OE, Bassey UE, Charles GE, Sambo EE, Akpan EJ.
Toxicological evaluation of some artemisinin combination therapies
(acts) on the kidney and liver of Wistar albino rats. International
Journal of Biochemistry Research and Review 2016;9:1–5.
- 9. Bhabagrahi R, Jyotirmoyee J, Satyajit S, Bandana R. Reproductive
profile of artemisinins in albino rats. Indian J Pharmacol 2010;42:
192–3.
- 10. El-Dakdoky MH. Evaluation of the developmental toxicity of
artemether during different phases of rat pregnancy. Food Chem
Toxicol 2009;47:1437–41.
- 11. Li Q, Weina PJ. Severe embryotoxicity of artemisinin derivatives in
experimental animals, but possibly safe in pregnant women.
Molecules 2009;15:40–57.
- 12. Clarke RL, Lerman SA, Cox EM, Gristwood WE, White TE.
Developmental toxicity of artesunate in the rat: comparison to other
artemisinins, comparison of embryotoxicity and kinetics by oral and
intravenous routes, and relationship to maternal reticulocyte count.
Birth Defects Res (Part B) 2008;83:397–406.
- 13. Longo M, Zanoncelli S, Torre PD, Riflettuto M, Cocco F. Effects
of the antimalarial drug dihydroartemisinin (DHA) on rat embryos
in vitro. Reprod Toxicol 2006;21:83–93.
- 14. Harpey JP, Darbois Y, Lefebvre G. Teratogenicity of pyrimethamine.
Lancet 1983:2:399.
- 15. Mesembe OE, Inyang AE, Udoaffah G, Igiri AO, Fischer VA,
Akpaso M, Eluwa MA. Akpa OA. A morphometric study of the teratogenic
effect of artesunate on the central nervous system of the
Wistar rat fetuses. Nigerian Journal of Physiological Sciences 2004;
19:1–12.
- 16. Eluwa MA, Otung GO, UDo-afah G, Ekanem TB, Mesembe OE,
Aligweke AU. Teratogenic effect of maternal administration of aloe
vera extract on fetal morphology and the histology of the fetal kidney.
Global Journal of Medical Sciences 2006;5:41–4.
- 17. Akpan TB, Ekanemesang UM, Ebong PE, Singh ED. Teratogenic
induction of skeletal anomalies by pyrimetamine (Daraprin) in
Wistar rats fetuses (Rattus Norvegicus): a morphological study. West
African Journal of Anatomy 1992;1:90–3.
- 18. Ekanem TB, Ekanemesang UM, Ekanem P. Teratogenic effect of
pyrimethamine in epiphysial rats fetuses. West African Journal of
Anatomy 1999;6:9–12.
- 19. Moore KL, Persuad TV. The Developing human. Clinically oriented
embryology. 7th ed. Philadelphia, PA: W. B. Saunders; 2003. p.
547–62.
- 20. Peter PW, Verhoef A, Hagenaars AM. Amniotic and maternal serum
alpha fetoprotein of rats with induced neural tube defect.
Scandinavian Acta of Morphology 1981;19:205–16.
- 21. Abd-Elmagid BF, Al-Gharudiz FB. Effect of administration of
haloperidol on the developing fetus of the chick embryo. Saudi J Biol
Sci 2005;15:297–306.
- 22. Zehra U, Tahir M, Jafferry FH, Lone KP. Ginkgo biloba effects of
mice fetal liver. Int J Morphol 2010;28:765–70.
- 23. Eluwa M, Ekere E, Ekanem T, Akpantah A, Igiri A. Teratogenic
effect of beer and palmwine on the histology of the fetal kidney of
Wistar rats. The Internet Journal of Toxicology 2009;6:1–5.